Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Puma Biotechnology (PBYI) Return on Assets (2017 - 2025)

Puma Biotechnology's Return on Assets history spans 9 years, with the latest figure at 0.15% for Q3 2025.

  • For Q3 2025, Return on Assets rose 4.0% year-over-year to 0.15%; the TTM value through Sep 2025 reached 0.15%, up 4.0%, while the annual FY2024 figure was 0.11%, 1.0% up from the prior year.
  • Return on Assets reached 0.15% in Q3 2025 per PBYI's latest filing, down from 0.22% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.22% in Q2 2025 to a low of 0.23% in Q1 2022.
  • Average Return on Assets over 5 years is 0.0%, with a median of 0.03% recorded in 2024.
  • The largest YoY upside for Return on Assets was 25bps in 2022 against a maximum downside of -12bps in 2022.
  • A 5-year view of Return on Assets shows it stood at 0.13% in 2021, then soared by 139bps to 0.05% in 2022, then soared by 98bps to 0.1% in 2023, then increased by 11bps to 0.11% in 2024, then surged by 40bps to 0.15% in 2025.
  • Per Business Quant, the three most recent readings for PBYI's Return on Assets are 0.15% (Q3 2025), 0.22% (Q2 2025), and 0.15% (Q1 2025).